Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1995 Feb;71(832):90–93. doi: 10.1136/pgmj.71.832.90

Effect of Helicobacter pylori eradication on peptic ulcer healing.

H J O'Connor 1, C Kanduru 1, A S Bhutta 1, J M Meehan 1, K M Feeley 1, K Cunnane 1
PMCID: PMC2397943  PMID: 7724441

Abstract

In a prospective study designed to assess the effect of Helicobacter pylori eradication on peptic ulcer healing, 85 consecutive patients with H. pylori-positive peptic ulcer disease were treated with a triple therapy regimen consisting of colloidal bismuth subcitrate 120 mg four times daily for 28 days, with metronidazole 400 mg three times daily and tetracycline 500 mg three times daily for the first seven days of treatment. H. pylori status was assessed by CLO test and histology at least four weeks after completing therapy. Of 75 patients (88%) H. pylori-negative after therapy, 69 (92%) had healed ulcers compared with only five of 10 patients (50%) who remained H. pylori-positive (p = 0.003). Cigarette smoking had no significant effect on ulcer healing. Our results suggest that H. pylori eradication may accelerate ulcer healing and provide further evidence that an effective helicobactericidal regimen is the treatment of choice in H. pylori-positive peptic ulcer.

Full text

PDF
90

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown K. E., Peura D. A. Diagnosis of Helicobacter pylori infection. Gastroenterol Clin North Am. 1993 Mar;22(1):105–115. [PubMed] [Google Scholar]
  2. Coghlan J. G., Gilligan D., Humphries H., McKenna D., Dooley C., Sweeney E., Keane C., O'Morain C. Campylobacter pylori and recurrence of duodenal ulcers--a 12-month follow-up study. Lancet. 1987 Nov 14;2(8568):1109–1111. doi: 10.1016/s0140-6736(87)91545-5. [DOI] [PubMed] [Google Scholar]
  3. Crabtree J. E., Taylor J. D., Wyatt J. I., Heatley R. V., Shallcross T. M., Tompkins D. S., Rathbone B. J. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet. 1991 Aug 10;338(8763):332–335. doi: 10.1016/0140-6736(91)90477-7. [DOI] [PubMed] [Google Scholar]
  4. Cutler A. F., Schubert T. T. Patient factors affecting Helicobacter pylori eradication with triple therapy. Am J Gastroenterol. 1993 Apr;88(4):505–509. [PubMed] [Google Scholar]
  5. George L. L., Borody T. J., Andrews P., Devine M., Moore-Jones D., Walton M., Brandl S. Cure of duodenal ulcer after eradication of Helicobacter pylori. Med J Aust. 1990 Aug 6;153(3):145–149. doi: 10.5694/j.1326-5377.1990.tb136833.x. [DOI] [PubMed] [Google Scholar]
  6. Graham D. Y., Lew G. M., Evans D. G., Evans D. J., Jr, Klein P. D. Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial. Ann Intern Med. 1991 Aug 15;115(4):266–269. doi: 10.7326/0003-4819-115-4-266. [DOI] [PubMed] [Google Scholar]
  7. Graham D. Y., Lew G. M., Klein P. D., Evans D. G., Evans D. J., Jr, Saeed Z. A., Malaty H. M. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med. 1992 May 1;116(9):705–708. doi: 10.7326/0003-4819-116-9-705. [DOI] [PubMed] [Google Scholar]
  8. Graham D. Y., Lew G. M., Malaty H. M., Evans D. G., Evans D. J., Jr, Klein P. D., Alpert L. C., Genta R. M. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology. 1992 Feb;102(2):493–496. doi: 10.1016/0016-5085(92)90095-g. [DOI] [PubMed] [Google Scholar]
  9. Hentschel E., Brandstätter G., Dragosics B., Hirschl A. M., Nemec H., Schütze K., Taufer M., Wurzer H. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med. 1993 Feb 4;328(5):308–312. doi: 10.1056/NEJM199302043280503. [DOI] [PubMed] [Google Scholar]
  10. Hosking S. W., Ling T. K., Yung M. Y., Cheng A., Chung S. C., Leung J. W., Li A. K. Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer. BMJ. 1992 Aug 29;305(6852):502–504. doi: 10.1136/bmj.305.6852.502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kikendall J. W., Evaul J., Johnson L. F. Effect of cigarette smoking on gastrointestinal physiology and non-neoplastic digestive disease. J Clin Gastroenterol. 1984 Feb;6(1):65–79. [PubMed] [Google Scholar]
  12. Lee A. H pylori-initiated ulcerogenesis: look to the host. Lancet. 1993 Jan 30;341(8840):280–281. doi: 10.1016/0140-6736(93)92624-3. [DOI] [PubMed] [Google Scholar]
  13. Marshall B. J., Goodwin C. S., Warren J. R., Murray R., Blincow E. D., Blackbourn S. J., Phillips M., Waters T. E., Sanderson C. R. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet. 1988 Dec 24;2(8626-8627):1437–1442. doi: 10.1016/s0140-6736(88)90929-4. [DOI] [PubMed] [Google Scholar]
  14. Marshall B. J., Warren J. R., Francis G. J., Langton S. R., Goodwin C. S., Blincow E. D. Rapid urease test in the management of Campylobacter pyloridis-associated gastritis. Am J Gastroenterol. 1987 Mar;82(3):200–210. [PubMed] [Google Scholar]
  15. McCarthy C. J., Collins R., Beattie S., Hamilton H., O'Morain C. Short report: treatment of Helicobacter pylori-associated duodenal ulcer with omeprazole plus antibiotics. Aliment Pharmacol Ther. 1993 Aug;7(4):463–466. doi: 10.1111/j.1365-2036.1993.tb00121.x. [DOI] [PubMed] [Google Scholar]
  16. O'Connor H. J., Dixon M. F., Wyatt J. I., Axon A. T., Dewar E. P., Johnston D. Campylobacter pylori and peptic ulcer disease. Lancet. 1987 Sep 12;2(8559):633–634. doi: 10.1016/s0140-6736(87)93031-5. [DOI] [PubMed] [Google Scholar]
  17. O'Connor H. J. Eradication of Helicobacter pylori: therapies and clinical implications. Postgrad Med J. 1992 Jul;68(801):549–557. doi: 10.1136/pgmj.68.801.549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rauws E. A., Langenberg W., Houthoff H. J., Zanen H. C., Tytgat G. N. Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology. 1988 Jan;94(1):33–40. [PubMed] [Google Scholar]
  19. Rauws E. A., Tytgat G. N. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet. 1990 May 26;335(8700):1233–1235. doi: 10.1016/0140-6736(90)91301-p. [DOI] [PubMed] [Google Scholar]
  20. Shelley E., Daly L., Kilcoyne D., Graham I., Mulcahy R. Risk factors for coronary heart disease: a population survey in County Kilkenny, Ireland, in 1985. Ir J Med Sci. 1991 Jan;160 (Suppl 9):22–28. doi: 10.1007/BF02950438. [DOI] [PubMed] [Google Scholar]
  21. Witteman E. M., Hopman W. P., Becx M. C., De Koning R. W., Tytgat G. N., Janssen A. J., Jansen J. B. Short report: smoking habits and the acquisition of metronidazole resistance in patients with Helicobacter pylori-related gastritis. Aliment Pharmacol Ther. 1993 Dec;7(6):683–687. doi: 10.1111/j.1365-2036.1993.tb00151.x. [DOI] [PubMed] [Google Scholar]
  22. Xia H. X., Daw M. A., Beattie S., Keane C. T., O'Morain C. A. Prevalence of metronidazole-resistant Helicobacter pylori in dyspeptic patients. Ir J Med Sci. 1993 Mar;162(3):91–94. doi: 10.1007/BF02942098. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES